Research Awards Listing
Research follows dollars, and The Lustgarten Foundation believes that increasing funds for pancreatic cancer research will translate into enhanced patient care, and ultimately, a cure.
The Lustgarten Foundation firmly believes that increasing funds for pancreatic cancer research is the surest path to improved patient care and eventually, to a cure. To date, we have committed nearly $120 million to providing the best and brightest minds with the resources to pursue the study and eradication of the disease.
View Award Listings by Year
2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000-1998
2003 Research Grants
Dana-Farber Cancer Institute
Nabeel Bardeesy, Ph.D.
Pancreatic Cancer Models for The Identification of Biomarkers and Tumor Maintenance Programs
Johns Hopkins Medical Institutions
Anirban Maitra, MBBS
Hedgehog Inhibitors of Pancreatic Cancer
Mayo Clinic College of Medicine
Janet Olsen, Ph.D.
Identification of Early Stage Pancreatic Cancer Biomarkers using LC-Dual ESI-FT-ICR Mass Spectrometry
Mayo Clinic at Rochester
Suresh T. Chari, M.D.
Serum Proteomics of Pancreatic Cancer- Induced Diabetes
Meharry Medical College and Vanderbilt University
Ana M. Grau, M.D.
Role of Rhob in Tumorigenesis and Metastasis In Pancreatic Cancer
Memorial Sloan-Kettering Cancer Center
Richard N. Kolesnick, M.D.
Development of KSR Phosphorothioate Antisense Oligonucleotides in the Treatment of Human Pancreatic Cancer
Mt. Sinai Hospital, Toronto / Samuel Lunenfeld Research Institute
Steven Gallinger, M.D.
A Novel Pancreatic Cancer Tumor Suppressor Candidate Gene
New York University School of Medicine
Daniel Meruelo, Ph.D.
Imaging-Assisted Design of Viral Vectors to Eradicate Metastatic Pancreatic Cancer
Paul Grippo, Ph.D.
Dual Targeting of Mutant Kras And Muchin1 in Mice That Develop Human Like Panins
Stanford University School of Medicine
Jonathan Pollack, M.D., Ph.D.
Locating Novel Pancreatic Cancer Genes with DNA Microarrays
State University of New York at Stony Brook
Dafna Bar-Sagi, Ph.D.
Analysis of Pancreatic Ductal Adenocarcinoma Progression in a Mouse Model of Hereditary Pancreatitis
University of Alabama at Birmingham
Pierre L. Triozzi, M.D.
ErbB Receptor Immunotherapy
University of California at San Francisco
Matthias Hebrok, Ph.D.
Embryonic Signaling Pathways in Pancreatic Cancer
University of Michigan Medical Center
Diane M. Simeone, M.D.
Development and Validation of Novel Biomarkers for Early Pancreatic Cancer Detection